Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Lytix Biopharma AS

LYTIX
Current price
6.9 NOK +0.6 NOK (+9.52%)
Last closed 6.68 NOK
ISIN NO0010405780
Sector Healthcare
Industry Biotechnology
Exchange Oslo Stock Exchange
Capitalization 316 244 647 NOK
Yield for 12 month +20.00 %
1Y
3Y
5Y
10Y
15Y
LYTIX
21.11.2021 - 28.11.2021

Lytix Biopharma ASA, a clinical stage biotech company, develops novel cancer immunotherapies for cancer therapy in Norway. Its lead product candidate is LTX-315, an oncolytic molecule that is developed for intratumoral injections, is designed for the local treatment of solid tumors that is in Phase II clinical trials. The company's products comprise of LTX-401, an oncolytic molecule for targeting deep-seated lesions, such as liver cancer and is in a preclinical phase. Lytix Biopharma ASA was incorporated in 2003 and is based in Oslo, Norway. Address: Sandakerveien 138, Oslo, Norway, 0484

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

176.79 NOK

P/E ratio

Dividend Yield

Current Year

+4 000 143 NOK

Last Year

+1 412 228 NOK

Current Quarter

Last Quarter

+10 550 124 NOK

Current Year

Last Year

Current Quarter

Last Quarter

Key Figures LYTIX

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -78 538 592 NOK
Operating Margin TTM -543.01 %
PE Ratio
Return On Assets TTM -53.28 %
PEG Ratio
Return On Equity TTM -105.16 %
Wall Street Target Price 176.79 NOK
Revenue TTM 14 476 102 NOK
Book Value 1.2 NOK
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY -100 %
Dividend Yield
Gross Profit TTM 7 668 535 NOK
Earnings per share -1.79 NOK
Diluted Eps TTM -1.79 NOK
Most Recent Quarter II 2024
Quarterly Earnings Growth YOY
Profit Margin

Dividend Analytics LYTIX

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History LYTIX

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor
Payout Ratio
Last Split Date
Dividend Date

Stock Valuation LYTIX

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue 18.9859
Price Sales TTM 21.846
Enterprise Value EBITDA -2.062
Price Book MRQ 5.5959

Financials LYTIX

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators LYTIX

For 52 weeks

4.61 NOK 15.03 NOK
50 Day MA 7.13 NOK
Shares Short Prior Month
200 Day MA 7.42 NOK
Short Ratio
Shares Short
Short Percent